These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 17614103

  • 21. Early terminal and nodal sprouting of motor axons after botulinum toxin.
    Pamphlett R.
    J Neurol Sci; 1989 Sep; 92(2-3):181-92. PubMed ID: 2809617
    [Abstract] [Full Text] [Related]

  • 22. Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor.
    Gurney ME, Yamamoto H, Kwon Y.
    J Neurosci; 1992 Aug; 12(8):3241-7. PubMed ID: 1494954
    [Abstract] [Full Text] [Related]

  • 23. An antibody to neural cell adhesion molecule impairs motor nerve terminal sprouting in a mouse muscle locally paralysed with botulinum toxin.
    Booth CM, Kemplay SK, Brown MC.
    Neuroscience; 1990 Aug; 35(1):85-91. PubMed ID: 2359498
    [Abstract] [Full Text] [Related]

  • 24. Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins.
    Thesleff S, Molgó J, Tågerud S.
    J Physiol (Paris); 1990 Aug; 84(2):167-73. PubMed ID: 2290131
    [Abstract] [Full Text] [Related]

  • 25. Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release.
    Angaut-Petit D, Molgó J, Faille L, Juzans P, Takahashi M.
    Brain Res; 1998 Jun 29; 797(2):357-60. PubMed ID: 9666170
    [Abstract] [Full Text] [Related]

  • 26. Muscle ciliary neurotrophic factor receptor α promotes axonal regeneration and functional recovery following peripheral nerve lesion.
    Lee N, Spearry RP, Leahy KM, Robitz R, Trinh DS, Mason CO, Zurbrugg RJ, Batt MK, Paul RJ, Maclennan AJ.
    J Comp Neurol; 2013 Sep 01; 521(13):2947-65. PubMed ID: 23504871
    [Abstract] [Full Text] [Related]

  • 27. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features.
    Angaut-Petit D, Molgó J, Comella JX, Faille L, Tabti N.
    Neuroscience; 1990 Sep 01; 37(3):799-808. PubMed ID: 1701041
    [Abstract] [Full Text] [Related]

  • 28. Age differences in morphological patterns of axonal sprouting and multiple innervation of neuromuscular junctions during muscle reinnervation following nerve crush injury.
    Zhou CJ, Kawabuchi M, Wang S, Liu WT, Hirata K.
    Ann Anat; 2002 Sep 01; 184(5):461-72. PubMed ID: 12392326
    [Abstract] [Full Text] [Related]

  • 29. Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.
    Caroni P, Schneider C, Kiefer MC, Zapf J.
    J Cell Biol; 1994 May 01; 125(4):893-902. PubMed ID: 7514606
    [Abstract] [Full Text] [Related]

  • 30. Motor nerve terminal sprouting in formamide-treated inactive amphibian skeletal muscle.
    Wines MM, Letinsky MS.
    J Neurosci; 1988 Oct 01; 8(10):3909-19. PubMed ID: 3264018
    [Abstract] [Full Text] [Related]

  • 31. Postnatal growth of motor nerve terminals in muscles of the mouse.
    Hopkins WG, Brown MC, Keynes RJ.
    J Neurocytol; 1985 Aug 01; 14(4):525-40. PubMed ID: 2415685
    [Abstract] [Full Text] [Related]

  • 32. Botulinum toxin type A: kinetics of calcium dependent paralysis of the neuromuscular junction and antagonism by drugs and animal toxins.
    Metezeau P, Desban M.
    Toxicon; 1982 Aug 01; 20(3):649-54. PubMed ID: 6125045
    [Abstract] [Full Text] [Related]

  • 33. Cytokines, growth factors and sprouting at the neuromuscular junction.
    English AW.
    J Neurocytol; 2003 Aug 01; 32(5-8):943-60. PubMed ID: 15034278
    [Abstract] [Full Text] [Related]

  • 34. Terminal sprouting is not responsible for enhanced transmitter release at disused neuromuscular junctions of the rat.
    Tsujimoto T, Umemiya M, Kuno M.
    J Neurosci; 1990 Jul 01; 10(7):2059-65. PubMed ID: 1973945
    [Abstract] [Full Text] [Related]

  • 35. Inactivity-induced motor nerve terminal sprouting in amphibian skeletal muscles chronically blocked by alpha-bungarotoxin.
    Wines MM, Letinsky MS.
    Exp Neurol; 1991 Jan 01; 111(1):115-22. PubMed ID: 1984426
    [Abstract] [Full Text] [Related]

  • 36. Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle.
    Harrison AR, Berbos Z, Zaldivar RA, Anderson BC, Semmer M, Lee MS, McLoon LK.
    Invest Ophthalmol Vis Sci; 2011 Feb 01; 52(2):982-6. PubMed ID: 21087967
    [Abstract] [Full Text] [Related]

  • 37. Exogenous ciliary neurotrophic factor (CNTF) reduces synaptic depression during repetitive stimulation.
    Garcia N, Santafé MM, Tomàs M, Priego M, Obis T, Lanuza MA, Besalduch N, Tomàs J.
    J Peripher Nerv Syst; 2012 Sep 01; 17(3):312-23. PubMed ID: 22971093
    [Abstract] [Full Text] [Related]

  • 38. Calcitonin gene-related peptide prevents disuse-induced sprouting of rat motor nerve terminals.
    Tsujimoto T, Kuno M.
    J Neurosci; 1988 Oct 01; 8(10):3951-7. PubMed ID: 2903917
    [Abstract] [Full Text] [Related]

  • 39. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.
    Meunier FA, Schiavo G, Molgó J.
    J Physiol Paris; 2002 Oct 01; 96(1-2):105-13. PubMed ID: 11755789
    [Abstract] [Full Text] [Related]

  • 40. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.
    Raghunath A, Perez-Branguli F, Smith L, Dolly JO.
    J Neurosci; 2008 Apr 02; 28(14):3683-8. PubMed ID: 18385326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.